Moleculin Biotech, Inc. - Common Stock, par value $.001 per share (MBRX)
Historical Holders from Q1 2024 to Q4 2025
-
Type / Class
-
Equity / Common Stock, par value $.001 per share
-
Symbol
-
MBRX on Nasdaq
-
Shares outstanding
-
31,794,008
-
Price per share
-
$0.28
-
All holders as of 30 Sep 2025
-
Q3 2025
-
Total 13F shares
-
778,273
-
Total reported value
-
$412,657
-
% of total 13F portfolios
-
0%
-
Share change
-
+345,621
-
Value change
-
+$243,574
-
Number of holders
-
24
-
Price from insider filings
-
$0.28
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Significant Owners of Moleculin Biotech, Inc. - Common Stock, par value $.001 per share (MBRX) based on Schedule 13D/G filings
| Filer |
Ownership |
Change % |
Holdings Value |
Net Change |
Nb Shares |
Change % |
Reporting Name |
Report Period |
|
ARMISTICE CAPITAL, LLC
|
5%
|
-44%
|
$872,587
|
+$185,087
|
1,586,521
|
+27%
|
Armistice Capital, LLC
|
30 Jun 2025
|
As of 30 Sep 2025,
Moleculin Biotech, Inc. - Common Stock, par value $.001 per share (MBRX) has
24
institutional shareholders
filing 13F forms.
They hold
778,273 shares.
of 31,794,008
outstanding shares (2.4%)
.
Institutional Holders of Moleculin Biotech, Inc. - Common Stock, par value $.001 per share (MBRX) across Reporting Periods
| Period |
Reported Shares, Excl. Options
|
Value, Excl. Options
|
Value Change
|
Puts Notional Value
|
Calls Notional Value
|
Price
|
Investors
|
|
2025 Q4
|
0
|
$0
|
-$18
|
|
|
$0.28
|
0
|
|
2025 Q3
|
778,273
|
$412,657
|
+$243,574
|
|
|
$0.53
|
24
|
|
2025 Q2
|
432,652
|
$130,873
|
-$1,202,132
|
|
|
$0.30
|
22
|
|
2025 Q1
|
1,478,032
|
$1,438,584
|
+$969,253
|
|
|
$0.97
|
21
|
|
2024 Q4
|
464,699
|
$790,000
|
+$6,340
|
|
|
$1.70
|
20
|
|
2024 Q3
|
460,563
|
$1,308,014
|
+$417,028
|
|
|
$2.84
|
17
|
|
2024 Q2
|
313,722
|
$1,103,728
|
+$192,754
|
|
|
$3.52
|
15
|
|
2024 Q1
|
258,464
|
$1,528,467
|
+$1,528,467
|
|
|
$5.91
|
18
|